Jury clears J&J of liability in New Jersey talc cancer case

Image
Reuters
Last Updated : Oct 12 2018 | 1:06 AM IST

By Tina Bellon

(Reuters) - A New Jersey jury on Thursday cleared Johnson & Johnson of liability in a case involving a woman who alleged that the company's talc-based products, including its baby powder, contain asbestos and caused her cancer.

After less than a day of deliberations, the jury in New Brunswick, New Jersey rejected claims by Rosalind Henry and her husband, who had alleged that Henry's mesothelioma, a cancer associated with asbestos exposure, was caused by the company's talc products.

J&J is facing some 10,600 liability lawsuits across the United States over its talc products, most involving claims that they caused ovarian cancer, and that the company knew of and concealed risks associated with the products.

The company, which is based just a few miles from the courtroom where the latest case took place, said it was pleased with the unanimous jury verdict.

"We have deep sympathy for anyone diagnosed with any form of cancer and appreciate that people are looking for answers. However, Johnson's baby powder is not the cause of this disease," the company said in a statement. It said decades of scientific testing by academic institutions and regulators have shown its talc to be safe and free of asbestos.

A lawyer for Henry did not immediately return a request for comment. During trial, Henry's lawyers said J&J had known for decades about asbestos fibres in its talc, but hid the evidence from regulators and consumers.

J&J has been fighting talc cancer lawsuits for several years, but the litigation shifted in recent months to include allegations of asbestos contamination.

Plaintiffs now claim asbestos fibres in the products are causing both ovarian cancer and mesothelioma.

In April, J&J lost the first trial over such allegations when a jury in New Jersey awarded $117 million to a man suffering from mesothelioma and his wife.

It lost another trial in May, when a California jury awarded $25.7 million to a woman diagnosed with mesothelioma. Both decisions are under appeal.

Since then, the company has had four mistrials in similar cases because jurors could not reach a verdict or because the plaintiff died.

In July, a Missouri jury hit J&J with a massive $4.69 billion verdict in the first trial alleging asbestos contamination has caused ovarian cancer in 22 women. That decision is also under appeal.

(Reporting by Tina Bellon; Editing by Bill Berkrot)

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 12 2018 | 12:55 AM IST

Next Story